Allogenic cell stem transplant (HSCT)
Showing 1 - 25 of >10,000
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)
Recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Mar 24, 2022
Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)
Completed
- Acute Myeloid Leukemia
- +2 more
- Fludarabine
- +3 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Allogenic Stem Cell Transplantation Trial (SAR445419)
Not yet recruiting
- Allogenic Stem Cell Transplantation
- (no location specified)
Feb 13, 2023
Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)
Not yet recruiting
- Thrombotic Disorder
- N-acetyl-cysteine
- +3 more
- (no location specified)
Jun 8, 2023
Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))
Not yet recruiting
- Transplantation, Hematopoietic Stem Cell
- Biological samples (blood and oral fluid)
-
Lyon, FranceHôpital de la Croix Rousse - service des maladies infectieuses e
Jul 7, 2023
Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)
Not yet recruiting
- Neoplasm
- Caregivers
- Sham VR
- Active VR
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 26, 2023
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Tacrolimus Blood Concentration and Transplant-related Outcomes
Recruiting
- Graft Vs Host Disease
- +2 more
- TAC C/D ratio
-
Trieste, ItalyIRCCS Burlo Garofolo
Oct 6, 2023
MDS Trial in Bari, Rozzano (bone marrow withdrawal)
Recruiting
- Myelodysplastic Syndromes
- bone marrow withdrawal
-
Bari, Italy
- +6 more
Oct 10, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Stress, Psychological, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Stress reduction
Completed
- Stress, Psychological
- Caregivers
- Stress reduction intervention
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Leukemia Trial (Prehabilitation)
Not yet recruiting
- Leukemia
- Prehabilitation
- (no location specified)
Dec 5, 2022
Knee Osteoarthritis Trial (Allogenic adipose derived mesenchymal stem cells (AD-MSC), Saline)
Not yet recruiting
- Knee Osteoarthritis
- Allogenic adipose derived mesenchymal stem cells (AD-MSC)
- Saline
- (no location specified)
Jun 26, 2023
Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)
Recruiting
- Hematopoietic Stem Cell Transplant (HSCT)
- Bronchiolitis Obliterans (BO)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 6, 2022
Immunobiology of Acute Myeloid Leukemia Relapses After
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Observations on Relapsed AML Allogeneic Transplanted patients
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jul 18, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant Trial in Stanford (Aromatherapy Inhaler)
Not yet recruiting
- Cancer Distress
- +3 more
- Aromatherapy Inhaler
-
Stanford, CaliforniaAubrey Florom-smith
Aug 8, 2022
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
Cytomegalovirus Infection Outcomes Among Hematopoietic Stem Cell
Not yet recruiting
- Cytomegalovirus (CMV)
- (no location specified)
Oct 11, 2022
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023